Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial. (2018)
Attributed to:
MRC Centre for Regenerative Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2468-1253(17)30326-6
PubMed Identifier: 29127060
Publication URI: http://europepmc.org/abstract/MED/29127060
Type: Journal Article/Review
Volume: 3
Parent Publication: The lancet. Gastroenterology & hepatology
Issue: 1